Compounds > cyclosporine

cyclosporine and B16 Melanoma

cyclosporine has been researched along with B16 Melanoma in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (23.08)	18.2507
2000's	5 (38.46)	29.6817
2010's	5 (38.46)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kambayashi, T; Nomura, S; Satake, A; Schmidt, AM	1
Gota, V; Mehta, M; Patel, K; Patil, A; Vavia, P	1
Chen, C; Li, TH; Meng, J; Shi, X; Sun, H; Sun, Y; Yu, T	1
Campistol, JM; Eggenhofer, E; Geissler, EK; Koehl, GE; Kroemer, A; Lang, SA; Lantow, M; Renner, P; Rovira, J; Sabet-Baktach, M; Schlitt, HJ	1
Buckner, CA; Cameron, D; Dotta, BT; Lafrenie, RF; Persinger, MA	1
Almaraz, A; Blanco, G; Fernández, N; López-Velasco, R; Morilla-Grasa, A; Ordóñez, JL; Rábano, G; Saornil-Alvarez, MA	1
Ciechomska, I; Golab, J; Kaminska, B; Kurzaj, Z; Legat, M; Mackiewicz, A; Wesolowska, A	1
Alvarez, MA; Ayesta, A; Boyano, MD; Cañavate, ML; Garcia De Galdeano, A; Garcia-Vazquez, MD; Smith-Zubiaga, I	1
Blanco, G; Diebold, Y; Domingo, E; López, R; Rábano, G; Saornil, AM; Tutor, CJ	1
Keil, D; Luebke, RW; Pruett, SB	1
Aoki, J; Kimura, Y; Kohno, M; Nakanishi, O; Ooka, H; Tsuruo, T	1
Charak, BS; Mazumder, A; Sadowski, RM	1
Agah, R; Charak, BS; Mazumder, A	1

Other Studies

13 other study(ies) available for cyclosporine and B16 Melanoma

Article	Year
Inhibition of calcineurin abrogates while inhibition of mTOR promotes regulatory T cell expansion and graft-versus-host disease protection by IL-2 in allogeneic bone marrow transplantation. PloS one, 2014, Volume: 9, Issue:3 Topics: Animals; Bone Marrow Transplantation; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Graft vs Host Disease; Immunosuppressive Agents; Interleukin-2; Lymphocyte Activation; Melanoma, Experimental; Mice; Receptors, Antigen, T-Cell; T-Lymphocytes, Regulatory; Tissue Donors; TOR Serine-Threonine Kinases; Transplantation, Homologous	2014
Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity. International journal of pharmaceutics, 2014, Sep-10, Volume: 472, Issue:1-2 Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Arginine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chickens; Clarithromycin; Cyclosporine; Cytochrome P-450 CYP3A Inhibitors; Drug Compounding; Gastrointestinal Tract; Hypromellose Derivatives; Ileum; Melanoma, Experimental; Mice; Nanoparticles; Paclitaxel; Particle Size; Rats, Sprague-Dawley; Skin Neoplasms; Surface Properties; Tumor Burden	2014
ABT-737 sensitizes curcumin-induced anti-melanoma cell activity through facilitating mPTP death pathway. Biochemical and biophysical research communications, 2015, Aug-14, Volume: 464, Issue:1 Topics: Adenine Nucleotide Translocator 1; Animals; Antineoplastic Agents; Biphenyl Compounds; Cell Death; Cell Line, Tumor; Curcumin; Cyclophilins; Cyclosporine; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Lactones; Melanoma, Experimental; Membrane Potential, Mitochondrial; Mice; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Nitrophenols; Peptidyl-Prolyl Isomerase F; Piperazines; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; Signal Transduction; Spiro Compounds; Sulfonamides	2015
Cyclosporine A Inhibits the T-bet-Dependent Antitumor Response of CD8(+) T Cells. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2016, Volume: 16, Issue:4 Topics: Animals; CD8-Positive T-Lymphocytes; Cyclosporine; Female; Graft Rejection; Graft Survival; Immune Tolerance; Immunosuppressive Agents; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Sirolimus; Skin Transplantation; T-Box Domain Proteins	2016
Biophoton emissions from cell cultures: biochemical evidence for the plasma membrane as the primary source. General physiology and biophysics, 2011, Volume: 30, Issue:3 Topics: Animals; Biophysics; Cell Culture Techniques; Cell Cycle; Cell Membrane; Cyclosporine; Epidermal Growth Factor; Flow Cytometry; Humans; Indoles; Maleimides; Melanoma, Experimental; Mice; Photons; Temperature; Time Factors	2011
Efficacy of five human melanocytic cell lines in experimental rabbit choroidal melanoma. Melanoma research, 2005, Volume: 15, Issue:1 Topics: Animals; Body Weight; Cell Line, Tumor; Choroid Neoplasms; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lung Neoplasms; Male; Melanocytes; Melanoma, Experimental; Penicillin G; Rabbits; Skin Neoplasms; Survival Rate	2005
Cyclosporine A and its non-immunosuppressive derivative NIM811 induce apoptosis of malignant melanoma cells in in vitro and in vivo studies. International journal of cancer, 2005, Oct-20, Volume: 117, Issue:1 Topics: Animals; Apoptosis; Blotting, Western; Caspases; Cell Survival; Cyclosporine; DNA, Neoplasm; Enzyme Activation; G1 Phase; Humans; In Vitro Techniques; Male; Melanoma, Experimental; Mice; Poly(ADP-ribose) Polymerases; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured	2005
Expression of IL-2 receptor beta-chain in B16 melanoma cells. The International journal of developmental biology, 1996, Volume: Suppl 1 Topics: Animals; Base Sequence; Cell Membrane; Cyclosporine; DNA Primers; Immunosuppressive Agents; Interleukin-2; Melanoma, Experimental; Mice; Polymerase Chain Reaction; Protein Conformation; Receptors, Interleukin-2; RNA, Messenger; Tumor Cells, Cultured	1996
Uveal melanoma model with metastasis in rabbits: effects of different doses of cyclosporine A. Current eye research, 2000, Volume: 21, Issue:3 Topics: Alanine Transaminase; Animals; Blood Urea Nitrogen; Body Weight; Creatinine; Cyclosporine; Follow-Up Studies; Immunosuppression Therapy; Immunosuppressive Agents; Kidney; Lung Neoplasms; Male; Melanoma, Experimental; Rabbits; Survival Rate; Tumor Cells, Cultured; Uveal Neoplasms	2000
Quantifying the relationship between multiple immunological parameters and host resistance: probing the limits of reductionism. Journal of immunology (Baltimore, Md. : 1950), 2001, Oct-15, Volume: 167, Issue:8 Topics: Animals; Cyclosporine; Dexamethasone; Female; Immune Tolerance; Immunity, Innate; Immunosuppressive Agents; Listeriosis; Melanoma, Experimental; Mice; Multivariate Analysis; Streptococcal Infections; Streptococcus agalactiae	2001
P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel. Cancer chemotherapy and pharmacology, 2002, Volume: 49, Issue:4 Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Caco-2 Cells; Cyclosporine; Cyclosporins; Humans; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Paclitaxel; Quinolines; Rats; Rats, Sprague-Dawley	2002
Antitumor effect of interferon plus cyclosporine A following chemotherapy for disseminated melanoma. Cancer research, 1992, Dec-01, Volume: 52, Issue:23 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Chromium; Cisplatin; Cyclosporine; Dacarbazine; Drug Synergism; Female; Immunotherapy, Adoptive; Interferons; Major Histocompatibility Complex; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Spleen; T-Lymphocytes, Regulatory	1992
Synergism of interleukin-2 and cyclosporine A in induction of a graft-versus-tumor effect without graft-versus-host disease after syngeneic bone marrow transplantation. Blood, 1992, Jul-01, Volume: 80, Issue:1 Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Cytotoxicity, Immunologic; Drug Synergism; Graft vs Host Disease; Histocompatibility Antigens Class II; Immunization, Passive; Immunotherapy; Interferon-gamma; Interleukin-2; Killer Cells, Lymphokine-Activated; Leukemia, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Recombinant Proteins; Spleen	1992